Target intelligence / Profile preview

Alpha-1A-adrenoceptor and Alpha-1D-adrenoceptor (α1A-adrenoceptor, α1D-adrenoceptor)

Target
α1A-adrenoceptor, α1D-adrenoceptor
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

**Alpha-1A-adrenoceptor** and **Alpha-1D-adrenoceptor** are closely related subtypes of the alpha-1 adrenergic receptor family, **G protein-coupled receptors** activated by catecholamines such as norepinephrine and epinephrine[5][4][3]. The α1A is prominent in the prostate, lower urinary tract, and certain vascular and neuronal tissues, mediating smooth muscle contraction involved in urinary tract function and vascular tone[7][4]. The α1D subtype predominates in specific vascular beds such as human epicardial coronary arteries, mediating vasoconstriction and contributing to blood pressure regulation[2][3]. Both subtypes are therapeutic targets for selective α1-blockers, which are used for hypertension and benign prostatic hyperplasia[5][2][4]. Ambiguous combined terms like "alpha-1A/1D adrenoceptor" are sometimes used to describe drugs or tissues where both subtypes are relevant, but for structured data, each should be handled separately as **Alpha-1A-adrenoceptor** and **Alpha-1D-adrenoceptor**[1][3][9]. **Note:** The target as presented, "alpha-1A/1D adrenoceptor," is **ambiguous/incorrect** for a canonical form because it attempts to merge two distinct, though related, subtypes. For structured databases, it is best to resolve to the two standard entities: "Alpha-1A-adrenoceptor" and "Alpha-1D-adrenoceptor."[3][9][1]

Other names
Alpha-1A adrenergic receptorAlpha-1D adrenergic receptorADRA1A (gene for α1A)ADRA1D (gene for α1D)Alpha-1-adrenoceptor (collective term for α1A, α1B, and α1D)Alpha-1C adrenergic receptor (historical for α1A)[3][7]Alpha-1A/D adrenoceptor (historical/ambiguous, used for tissues where both are detected)[1][3][9]Alpha-adrenergic receptor 1a (unclear, sometimes used for α1A)[6]
02

Mechanism of action

Antagonism (blockade) of α1A and/or α1D-adrenoceptor to cause smooth muscle relaxation (vasodilation, decreased peripheral resistance, relief of urinary tract obstruction) - Inhibition of vasoconstrictive effects mediated by norepinephrine/epinephrine[5][2][4]

03

Biological functions

Signal transductionSmooth muscle contractionVasoconstrictionRegulation of arterial blood pressureRegulation of urinary sphincter and ureter functionModulation of neurotransmission[5][4][1][3]
04

Disease associations

Cardiovascular disease (e.g., hypertension)[2][3][4][5]Benign prostatic hyperplasia (BPH)Lower urinary tract symptomsPossibly roles in neurodegenerative disease and other pathologies[4][8][5]
05

Safety considerations

Orthostatic hypotensionDizziness and syncopePotential cardiovascular events (palpitations, arrhythmias)Ejaculatory dysfunction (with some α1-blockers)Interaction with antihypertensive agentsRisk of falls (particularly in elderly)[4][5][2]
06

Interacting drugs

Alfuzosin

6 more in the full profile.

07

Biomarkers

Expression of ADRA1A or ADRA1D mRNA/protein (sometimes used in tissue characterization or pharmacologic studies)[2][9]No common clinical biomarkers for patient selection/monitoring established

Beyond the preview

Go deeper on Alpha-1A-adrenoceptor and Alpha-1D-adrenoceptor (α1A-adrenoceptor, α1D-adrenoceptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1A-adrenoceptor and Alpha-1D-adrenoceptor (α1A-adrenoceptor, α1D-adrenoceptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call